{"id":"W4318715566","doi":"10.1136/rmdopen-2022-002559","title":"Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study","year":2023,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Placebo; Internal medicine; Dermatology; Psoriasis; Arthritis; Double blind; Rheumatoid arthritis; Physical therapy; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003343561,0.0002444593,0.001220549,0.0001760486,0.0001084491,0.00003302334,0.000111369,0.00004669531,0.000101377],"category_scores_gemma":[0.0001763411,0.0001633508,0.00006353988,0.0005147268,0.00005729905,0.0001526009,0.0001761184,0.0001212853,0.00001790239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004362419,"about_ca_system_score_gemma":0.00006584456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003018928,"about_ca_topic_score_gemma":0.000702595,"domain_scores_codex":[0.9984485,0.00009546793,0.0004991688,0.0003760224,0.0003040531,0.0002767901],"domain_scores_gemma":[0.9990537,0.0002910465,0.0001753596,0.0002640758,0.0001005413,0.0001152453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.860242,0.004199991,0.09704673,0.00002734899,0.0009362465,0.0001860335,0.002761723,0.000005120921,0.000003772776,0.000004762507,0.00002417734,0.03456206],"study_design_scores_gemma":[0.7811052,0.002799008,0.2143337,0.0002609568,0.0001968382,0.000003803963,0.001092654,0.00001680536,0.00001544244,0.00001096663,0.00004525729,0.0001194466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815642,0.0002106432,0.000001145425,0.00008787751,0.00006824383,0.01644639,0.000106101,0.00002771847,0.001487679],"genre_scores_gemma":[0.9979292,0.0002499444,0.00003284496,0.00002730573,0.0000257293,0.001382595,0.0001561332,0.00002696625,0.0001692581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1172869,"threshold_uncertainty_score":0.6661251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02207100793051609,"score_gpt":0.3343654851094717,"score_spread":0.3122944771789556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}